Greycoat Research Expert Guidance for CKD Cats
With over 1,000 consultation cases worldwide, Greycoat Research provides expert-backed guidance for CKD cats, helping them maintain kidney health and manage the progression of CKD through data-driven care.
Dr. Toru Miyazaki was the first to uncover the mechanism behind cat CKD.
Dr. Toru Miyazaki, the world's leading authority on AIM research, provides Greycoat Research with expert guidance in developing AIM-based supplementation to support kidney function. His research has contributed to innovative treatments that help manage CKD in cats.
Jelly, a 6-year-old Abyssinian, had fluctuating kidney values since she was 2–3 years old. While she had periods of stable levels, her creatinine and BUN had reached a concerning range, putting her at risk for CKD stage 2. Her owner began supplementing with AIM-based support, and within 4 months, Jelly’s kidney values had returned to a normal range.
Meet Jelly
- Breed: Abyssinian
- Age: 6 years
- Sex: Spayed Female
- Weight: 4.5 kg
- Condition: Borderline Stage 2 CKD (before treatment)
- Symptoms Before Treatment: Fluctuating kidney values, risk of CKD progression
- Previous Diet & Treatments: Renal supplements, probiotics, omega-3
Jelly’s Health Improvements
Jelly began AIM supplementation in March 2024. By July, her kidney values had normalized.
| Health Metric | Before | After | Change |
|---|---|---|---|
| Creatinine (CRE) | 1.93 | 1.68 | Decreased (improved kidney waste filtration) |
| BUN Levels | 33.3 | 25.0 | Decreased (better nitrogen waste management) |
| SDMA Levels | 16.6 | 10.3 | Normalized (kidney function stabilized) |
| Weight | 4.5 kg | 4.5 kg | No weight loss |
How Did Jelly Improve?
Energy & Activity
- Maintained normal energy levels with no noticeable fatigue.
Weight & Appetite
- Weight remained stable at 4.5 kg.
Appearance & Other Changes
- No noticeable coat or eye changes were reported, indicating general stability.
Supplement Adjustments
- Initially given renal supplements, probiotics, and omega-3.
- Started Dr. Toru Protocol in March 2024.
- Continued AIM supplementation while monitoring kidney values.
At the start of AIM-based supplementation, Jelly’s kidney values were fluctuating within a concerning range. After 4 months of consistent supplementation and monitoring, her creatinine, BUN, and SDMA levels improved, returning to a normal range. These results suggest that AIM-based care and expert guidance played a significant role in stabilizing her kidney health.
Testimonial from Jelly’s Owner
"Jelly’s kidney values had been a concern for years, fluctuating between normal and borderline. Her creatinine and BUN levels often spiked, which was worrisome. After starting the supplements, I was amazed to see her values return to a normal range in just 4 months! I’m grateful for Greycoat Research’s guidance and support."
Help Your Cat Live Healthier with CKD Support
CKD is a progressive and irreversible disease that gradually impairs kidney function. Because many cats show no symptoms until significant damage has occurred, early detection and management is key to delaying its progression and preserving quality of life.
Greycoat Research has provided consultations for over 1,000 cats, with 97% of stage 2 and 3 cats showing improved kidney health after following our tailored management plans. If your cat has been diagnosed with CKD or has high creatinine levels, taking action now can lead to lasting improvements.
- Try AIM-based supplements, including Dr. Toru Protocol, along with additional kidney support.
- Monitor kidney health regularly and adjust treatment plans as needed.
- Schedule a free consultation with Greycoat Research for expert guidance.
